< Terug naar vorige pagina

Publicatie

Recent advances in oral vaccine development: yeast-derived β-glucan particles

Tijdschriftbijdrage - Review Artikel

Ondertitel:Recent advances in oral vaccine development : yeast-derived beta-glucan particles
Oral vaccination is the most challenging vaccination method due to the administration route. However, oral vaccination has socio-economic benefits and provides the possibility of stimulating both humoral and cellular immune responses at systemic and mucosal sites. Despite the advantages of oral vaccination, only a limited number of oral vaccines are currently approved for human use. During the last decade, extensive research regarding antigen-based oral vaccination methods have improved immunogenicity and induced desired immunological outcomes. Nevertheless, several factors such as the harsh gastro-intestinal environment and oral tolerance impede the clinical application of oral delivery systems. To date, human clinical trials investigating the efficacy of these systems are still lacking. This review addresses the rationale and key biological and physicochemical aspects of oral vaccine design and highlights the use of yeast-derived β-glucan microparticles as an oral vaccine delivery platform.
Tijdschrift: HUMAN VACCINES & IMMUNOTHERAPEUTICS
ISSN: 2164-5515
Issue: 5
Volume: 10
Pagina's: 1309 - 1318
Jaar van publicatie:2014